InfectoPharm conducts extensive clinical studies in compliance with the latest medical standards at independent clinics and research institutes, almost exclusively in Germany. We collaborate with respected experts in their field, who closely accompany our studies. This ensures that InfectoPharm can continue to offer high-quality and effective medications in the future.
InfectoPharm products always reflect the latest state-of-the-art in medical science, thus guaranteeing both efficacy and safety.
We want to achieve significant improvements for patients. This is particularly true for children, who are still affected by an inadequate supply of medications. Therefore, we are always keen to break new grounds, e.g. in the treatment of cystic fibrosis or severe infections with problematic germs that do not respond to standard antibiotics. The same also applies to everyday issues such as lice infestations or scabies.
The impact of our products – after clinical testing, approval and market entry – motivates us to continue pursuing research in precisely this way.